+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of insulin binding to the erythroleukemia cell line K 562



Characterization of insulin binding to the erythroleukemia cell line K 562



Biochemical and Biophysical Research Communications 117(3): 823-834



The K 562 is a transformed human erythroid stemcell and is used as a target cell for NK-T-cells. In this study the presence of insulin receptors in K 562 is established. The best binding and negative cooperativity was found in the two Hepes containing buffers whereas no cooperativity was obtained in the Krebs-Ringer buffer. The calculated affinity constants and receptor number per cell varied according to the buffer. Preincubation with insulin caused a down-regulation of the insulin binding capacity. 10 ng/ml caused a lowering of the affinity, with an unchanged number of receptors. 100 ng/ml caused a decrease in receptor number with unchanged affinity. These results were found in both Hepes and Krebs-Ringer phosphate buffer. IGF-I shows cross-reactivity with the insulin receptor, with a potency of 12 and 100 times less than insulin in Krebs-Ringer phosphate buffer and G-buffer respectively. However, no specific IGF-I receptors were found. The presence of receptors on K 562 cells suggests a biological role for insulin. The different results in the different buffers, indicate that a buffer containing Hepes and/or Tris, is required to expose negative cooperativity and make the receptors more accessible to insulin.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042514176

Download citation: RISBibTeXText

PMID: 6582851

DOI: 10.1016/0006-291x(83)91671-6


Related references

The binding of insulin-like growth factor II to the erythroleukemia cell line K562. Bioscience Reports 4(12): 1071-1077, 1984

Characterization of insulin-like growth factor I receptors on human erythroleukemia cell line (K-562 cells). Endocrinologia Japonica 34(1): 81-88, 1987

Characterization of insulin-binding to the hepatoma cell line H35. Acta Endocrinologica 112(4): 559-564, 1986

Generation and characterization of a JAK2V617F-containing erythroleukemia cell line. Plos one 9(7): E99017, 2014

Characterization of the stem cell factor scf receptor on a human erythroleukemia cell line ocim1. Clinical & Investigative Medicine 15(4 Suppl.): A55, 1992

Characterization of erythropoietin responsive rauscher erythroleukemia cell line. Experimental Hematology (charlottesville): 450, 1986

Characterization of fc gamma receptors on a human erythroleukemia cell line hei. Experimental Hematology (Charlottesville) 20(5): 576-581, 1992

Characterization and induction of a cell line established from a patient with erythroleukemia (FAB M6). Nihon Ketsueki Gakkai Zasshi 53(1): 35-44, 1990

Erythropoietin binding and induced differentiation of Rauscher erythroleukemia cell line red 5-1.5. Journal of Biological Chemistry 264(3): 1804-1810, 1989

Characterization of ligand binding and processing by bombesin receptors in an insulin-secreting cell line. Biochemical Journal 247(3): 731-738, 1987

Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood 82(2): 436-444, 1993

Partial purification of an IGF-II receptor/binding protein from the erythroleukemia cell line K562. Molecular & Cellular Biochemistry. 154(1): 47-54, 1996

Characterization of the chimeric erythropoietin receptor fusion protein in the TF-1 erythroleukemia cell line. American Journal of Human Genetics 69(4 Suppl.): 258, 2001